MAPT and Alzheimer disease: Because the levels of tau protein and of its phosphorylated form are increased in the brain of OXYS rats already at age 3 months [28], we then evaluated the ability of SkQ1 to slow down the hyperphosphorylation of tau protein in the hippocampus during progression of AD-like pathology.